Ardelyx Stock plunges After FDA detects deficiencies in Its Kidney Disease Candidate Pitch
Ardelyx Stock plummeted after FDA discovery Ardelyx is a biopharmaceutical enterprise focusing on discovering, developing, and commercializing new first-class drugs for people with kidney and cardiorenal diseases, in order…